Ming Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ming Shen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Bartosz Szmyd
Department of Neurosurgery and Neurooncology, Barlicki University Hospital, Medical University of Łódź, 90-153 Łódź, Poland
1 shared publication - Caroline Apra
Neurosurgery Department, Henri Mondor University Hospital, AP-HP, Creteil, France; Paris-Est Créteil - Val de Marne University, Creteil, France; INSERM U955, Mondor Biomedical Research Institute, Creteil, France; GRCT Optima, Creteil, France
1 shared publication - Dariusz Jan Jaskólski
Department of Neurosurgery and Neurooncology, Barlicki University Hospital, Medical University of Łódź, 90-153 Łódź, Poland
1 shared publication - Emmanuel Jouanneau
Hospices Civils de Lyon, Service de Neurochirurgie, Lyon
1 shared publication - Ernest Jan Bobeff
Department of Neurosurgery and Neuro-Oncology, Medical University of Lodz, Barlicki University Hospital, Kopcinskiego St. 22, 90-153 Lodz, Poland
1 shared publication Haixia Cheng
Department of Pathology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
Comparative Outcomes of Gross Total Resection vs. Subtotal Resection Plus Radiotherapy for Preventing Craniopharyngioma Recurrence: A Meta-Analysis of the Endoscopic Endonasal Approach
Objective: Craniopharyngioma recurrence risk studies comparing gross total resection (GTR) vs. subtotal resection (STR) with radiotherapy (XRT) provide inconclusive or contradictory results. This may be an effect of the small group sizes and diversity in the approaches used. Currently, the endoscopic endonasal approach (EEA) is preferred in craniopharyngioma management. Here, we aimed to perform a meta-analysis comparing recurrence risk after GTR vs. STR plus XRT in patients treated with the EEA regimen. Methods: We performed a systematic literature search of original English language papers on craniopharyngioma management published in the PubMed, Web of Science, and Scopus databases up to 18 October 2023. Eleven articles included data on recurrence rate after EEA: GTR vs. STR with XRT. We extracted the year of publication, number of patients, surgical approach, extent of resection, and follow-up duration. We used meta-analysis for the odds ratio (OR) in fixed and random effects models and Egger’s and Begg’s tests to assess heterogeneity and publication bias. Follow-up duration and time to recurrence were additionally included in Kaplan–Meier curves with log-rank test analysis. Results: We observed a lower recurrence rate in patients after GTR (10%) as compared to STR with XRT (30%), OR = 0.299, p < 0.001. To increase data reliability, we limited our analysis to studies with at least five patients in each subgroup and also observed lower recurrence in patients after GTR (12%) as compared to STR with XRT (27%), OR = 0.376, p = 0.011. Survival analysis confirmed significant differences in recurrence-free survival percentages between these groups (p = 0.008). Conclusions: To date, this is the largest meta-analysis evaluating the recurrence risk in patients undergoing EEA for craniopharyngioma resection, comparing outcomes between those treated with GTR and those treated with STR plus XRT. The results suggest that GTR significantly reduces recurrence risk.
Open AccessComparative Outcomes of Gross Total Resection vs. Subtotal Resection Plus Radiotherapy for Preventing Craniopharyngioma Recurrence: A Meta-Analysis of the Endoscopic Endonasal Approach
Objective: Craniopharyngioma recurrence risk studies comparing gross total resection (GTR) vs. subtotal resection (STR) with radiotherapy (XRT) provide inconclusive or contradictory results. This may be an effect of the small group sizes and diversity in the approaches used. Currently, the endoscopic endonasal approach (EEA) is preferred in craniopharyngioma management. Here, we aimed to perform a meta-analysis comparing recurrence risk after GTR vs. STR plus XRT in patients treated with the EEA regimen. Methods: We performed a systematic literature search of original English language papers on craniopharyngioma management published in the PubMed, Web of Science, and Scopus databases up to 18 October 2023. Eleven articles included data on recurrence rate after EEA: GTR vs. STR with XRT. We extracted the year of publication, number of patients, surgical approach, extent of resection, and follow-up duration. We used meta-analysis for the odds ratio (OR) in fixed and random effects models and Egger’s and Begg’s tests to assess heterogeneity and publication bias. Follow-up duration and time to recurrence were additionally included in Kaplan–Meier curves with log-rank test analysis. Results: We observed a lower recurrence rate in patients after GTR (10%) as compared to STR with XRT (30%), OR = 0.299, p < 0.001. To increase data reliability, we limited our analysis to studies with at least five patients in each subgroup and also observed lower recurrence in patients after GTR (12%) as compared to STR with XRT (27%), OR = 0.376, p = 0.011. Survival analysis confirmed significant differences in recurrence-free survival percentages between these groups (p = 0.008). Conclusions: To date, this is the largest meta-analysis evaluating the recurrence risk in patients undergoing EEA for craniopharyngioma resection, comparing outcomes between those treated with GTR and those treated with STR plus XRT. The results suggest that GTR significantly reduces recurrence risk.
- Open Access
- 30 June 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (26)
Endoscopic endonasal surgery using indocyanine green fluorescence endoscope for Cushing’s disease caused by mixed intrasellar gangliocytoma and adrenocorticotropin adenoma: illustrative case
BACKGROUND: Mixed gangliocytoma-adenoma (MGA) is an uncommon tumor found in the sellar region, characterized by both gangliocytic and pituitary adenomatous components. Preoperative differentiation of these mixed tumors from typical pituitary adenomas can be challenging, making thorough histological examination following resection essential for accurate diagnosis. However, the presence of the neural component in the gangliocytoma does not seem to affect its aggressiveness or recurrence risk after surgery. OBSERVATIONS: In the present study, the authors report a case of Cushing’s disease secondary to a mixed pituitary adrenocorticotropin adenoma coexisting with an intrasellar gangliocytoma. Innovative preoperative C-X-C chemokine receptor type 4 (CXCR4)–targeted positron emission tomography (PET)/MRI and an intraoperative indocyanine green (ICG) fluorescence endoscope were used to localize the pathology. Biochemical remission was achieved after gross-total resection. LESSONS: Gross-total resection of the tumor is a curative management strategy for MGAs. MGA should be suspected if the intraoperative frozen section shows gliosis with ganglion-like neurons but not adenomas. Preoperative CXCR4-targeted PET/MRI can help to localize the pathology causing Cushing’s disease. An intraoperative ICG fluorescence endoscope can be used to differentiate the pathology from normal gland tissue. https://thejns.org/doi/10.3171/CASE25237
- 30 June 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (26)
Open AccessEndoscopic endonasal surgery using indocyanine green fluorescence endoscope for Cushing’s disease caused by mixed intrasellar gangliocytoma and adrenocorticotropin adenoma: illustrative case
BACKGROUND: Mixed gangliocytoma-adenoma (MGA) is an uncommon tumor found in the sellar region, characterized by both gangliocytic and pituitary adenomatous components. Preoperative differentiation of these mixed tumors from typical pituitary adenomas can be challenging, making thorough histological examination following resection essential for accurate diagnosis. However, the presence of the neural component in the gangliocytoma does not seem to affect its aggressiveness or recurrence risk after surgery. OBSERVATIONS: In the present study, the authors report a case of Cushing’s disease secondary to a mixed pituitary adrenocorticotropin adenoma coexisting with an intrasellar gangliocytoma. Innovative preoperative C-X-C chemokine receptor type 4 (CXCR4)–targeted positron emission tomography (PET)/MRI and an intraoperative indocyanine green (ICG) fluorescence endoscope were used to localize the pathology. Biochemical remission was achieved after gross-total resection. LESSONS: Gross-total resection of the tumor is a curative management strategy for MGAs. MGA should be suspected if the intraoperative frozen section shows gliosis with ganglion-like neurons but not adenomas. Preoperative CXCR4-targeted PET/MRI can help to localize the pathology causing Cushing’s disease. An intraoperative ICG fluorescence endoscope can be used to differentiate the pathology from normal gland tissue. https://thejns.org/doi/10.3171/CASE25237